RXST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RxSight Inc (RXST) is not a strong buy for a beginner, long-term investor at this time. The stock lacks clear positive catalysts, has mixed technical indicators, and its financial performance shows declining revenue despite improved margins. Analysts maintain neutral ratings with limited upside potential, and there are no significant trading trends or influential figures backing the stock. Given the investor's background and goals, holding off on investing in RXST is recommended.
The MACD is positive and expanding, suggesting slight bullish momentum. However, the RSI is neutral at 54.855, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The stock is trading near resistance levels (R1: 6.749) with limited upside potential.
Improved gross margin (+8.21% YoY) and net income (+54.13% YoY) in Q4 2025, indicating better cost management.
Analysts have lowered price targets, and the company’s 2026 revenue guidance is below expectations. No significant news, hedge fund activity, or insider trading trends. Lack of congress trading data.
In Q4 2025, revenue decreased significantly (-18.91% YoY), but net income and EPS improved (-0.22 EPS, up 46.67% YoY). Gross margin increased to 77.47%, showing better operational efficiency despite declining sales.
Analysts maintain neutral ratings with price targets ranging from $9 to $10, reflecting limited upside potential. Recent adjustments to models indicate cautious sentiment due to weaker 2026 revenue guidance.
